Literature DB >> 2117775

Immunoglobulin V regions of a bactericidal anti-Neisseria meningitidis outer membrane protein monoclonal antibody.

J W Larrick1, M J Coloma, J del Valle, M E Fernandez, K E Fry, J V Gavilondo-Cowley.   

Abstract

C6 is a potentially therapeutic murine monoclonal antibody that recognizes the class 1 outer membrane protein of Neisseria meningitidis. C6 specifically immunoblots this antigen and augments in vitro killing of N. meningitidis bacteria. We describe a general method of obtaining the heavy and light chain variable-region sequence from immunoglobulin-secreting cells. The method uses mixed polymerase chain reaction (PCR) primers designed from the 5' end of the framework 1 (FR1) sequences of the heavy and light chains, and 3'-end primers for constant-region conserved sequences. The method has been applied to the cloning and sequencing of the variable region of C6 to construct a humanized monoclonal antibody. Rapid amplification and sequencing of variable regions by this general method have multiple applications in the study of the immune response to infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117775     DOI: 10.1111/j.1365-3083.1990.tb02901.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Rapid cloning of any rearranged mouse immunoglobulin variable genes.

Authors:  A K Dattamajumdar; D P Jacobson; L E Hood; G E Osman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.

Authors:  M A Walls; K C Hsiao; L J Harris
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

3.  Fv structure of monoclonal antibody II-481 against herpes simplex virus Fc gamma-binding glycoprotein gE contains immunodominant complementarity determining region epitopes that react with human immunoglobulin M rheumatoid factors.

Authors:  P J Johansson; C Malone; W Swietnicki; B M Dunn; R C Williams
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.